Page last updated: 2024-09-03

troxacitabine and Cancer of Kidney

troxacitabine has been researched along with Cancer of Kidney in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Belanger, K; Bjarnason, GA; Chi, K; Ernst, DS; Goel, R; Jolivet, J; McIntosh, L; Moore, MJ; Ruether, JD; Seymour, L; Siu, LL; Stewart, D; Tannock, I; Townsley, CA	1
Angers, EG; Attardo, G; Bednarski, K; Bibeau, L; Bowlin, TL; Cimpoia, A; DeMuys, JM; Kadhim, SA; Waud, WR	1
Attardo, G; Cerna, C; Davidson, K; Finkle, C; Gomez, L; Izbicka, E; Lawrence, R; Marsolais, C; Rowinsky, EK; Siu, LL; Von Hoff, DD	1

Trials

1 trial(s) available for troxacitabine and Cancer of Kidney

Article	Year
Phase II study of troxacitabine (BCH-4556) in patients with advanced and/or metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada-Clinical Trials Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Apr-15, Volume: 21, Issue:8 Topics: Aged; Antineoplastic Agents; Canada; Carcinoma, Renal Cell; Cytosine; Dioxolanes; Disease Progression; Drug Administration Schedule; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Treatment Outcome	2003

Article

Year

Phase II study of troxacitabine (BCH-4556) in patients with advanced and/or metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada-Clinical Trials Group.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Apr-15, Volume: 21, Issue:8

Topics: Aged; Antineoplastic Agents; Canada; Carcinoma, Renal Cell; Cytosine; Dioxolanes; Disease Progression; Drug Administration Schedule; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Treatment Outcome

2003

Other Studies

2 other study(ies) available for troxacitabine and Cancer of Kidney

Article	Year
Potent antitumor activity of a novel nucleoside analogue, BCH-4556 (beta-L-dioxolane-cytidine), in human renal cell carcinoma xenograft tumor models. Cancer research, 1997, Nov-01, Volume: 57, Issue:21 Topics: Animals; Antineoplastic Agents; Carcinoma, Renal Cell; Cytosine; Dioxolanes; Drug Screening Assays, Antitumor; Female; Humans; Kidney Neoplasms; Mice; Neoplasm Transplantation; Nucleosides; Transplantation, Heterologous; Tumor Cells, Cultured	1997
Activity of (-)-2'-deoxy-3'-oxacytidine (BCH-4556) against human tumor colony-forming units. Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9, Issue:8 Topics: Antineoplastic Agents; Cytosine; Dioxolanes; Female; Humans; Kidney Neoplasms; Melanoma; Ovarian Neoplasms; Tumor Cells, Cultured; Tumor Stem Cell Assay	1998

Article

Year

Potent antitumor activity of a novel nucleoside analogue, BCH-4556 (beta-L-dioxolane-cytidine), in human renal cell carcinoma xenograft tumor models.

Cancer research, 1997, Nov-01, Volume: 57, Issue:21

Topics: Animals; Antineoplastic Agents; Carcinoma, Renal Cell; Cytosine; Dioxolanes; Drug Screening Assays, Antitumor; Female; Humans; Kidney Neoplasms; Mice; Neoplasm Transplantation; Nucleosides; Transplantation, Heterologous; Tumor Cells, Cultured

1997

Activity of (-)-2'-deoxy-3'-oxacytidine (BCH-4556) against human tumor colony-forming units.

Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9, Issue:8

Topics: Antineoplastic Agents; Cytosine; Dioxolanes; Female; Humans; Kidney Neoplasms; Melanoma; Ovarian Neoplasms; Tumor Cells, Cultured; Tumor Stem Cell Assay

1998